The enablers of safer surgery

Email us at


Visa Sippola
CEO, Co-Founder

Shahab Haeri
CTO, Co-Founder

Jukka Kreander
CQRO, Co-Founder

Tom Rönnlund
Chief Commercial Officer

Anna Prudan
Quality Engineer

Junaid Akhtar
Engineering Design Manager

Julia Peltola
Business Controller

Kaisa Kähkönen
Product Specialist – Finland

Panu Pesonen
Manufacturing Engineer

Soudabeh Bakhtiari
Production Engineer

Board of Directors

Lex R. Giltaij, M.D. & M.B.A.
Chairman of the Board

With 30+-years of repeated success in build-up of new international markets and businesses in medical device (both capital goods & implants), biotech and biomaterials industry. From start to successful exit in all aspects. Instrumental in achieving ~1 Billion USD shareholder value in Endoscopy, Orthopedics & Spine.

Dr. Giltaij holds a MD from Utrecht University, The Netherlands, a MBA from Henley Management College, UK and is educated as certified board member at TIAS University, Tilburg The Netherlands.

Adriaan Hart de Ruijter
Board Member

Adriaan founded Cascara Ventures to create value in life science, combining his experience as entrepreneur with venture capital finance. Cascara focuses on medical devices and digital healthcare in surgery, cardiology and immunotherapy.

Adriaan previously founded MSOURCE, the CRO for the medical device, biotech and pharmaceutical industry. In his role as CEO he worked together with many medical device and pharmaceutical companies to develop and run their clinical and commercial programs. MSOURCE was sold to TUV-SUD, a leading certification company and Notified Body for the device industry in 2008. Adriaan presently serves on the board of several life science companies.

Adriaan holds an M.D. degree from the University of Leiden and an MBA from the Erasmus University of Rotterdam in the Netherlands.

Andreas Bunge
Board Member

Now working as an active private investor and adviser. Andreas has extensive record from developing companies, as an entrepreneur, CEO, chairman, board member, founder and investor. Actively engaged in business development and financing (including several IPOs). Founded and also served as CEO and board member of Accelerator Nordic, a life science venture and investment company.

He has been active in different roles in several private and listed companies within life science, software and technology such as, Intentia AB, Applied Sensor AB, Pledpharma AB (Egetis therapeutics), Spago Nanomedical AB, Syntheticmr AB and Neonode Inc.

Andreas Bunge has an MSc in Engineering and Management from Linköping University, Sweden.

Juho Risku
Board Member

In the fore front of digital technologies from mid -80s, serial entrepreneur since 1996, founder in four companies, M.Sc. in Economics (thesis about the effects of VC-Founder relationship quality), VC since 2012, participated 100+ investment rounds, visionary technology guy and an enthusiast ice climber and mountaineer.

Juho is often the first contact for a startup at Butterfly Ventures. He’s passionate about great products and enjoys taking deep dives in to the competitive landscape. He’s customer value driven, knows a lot about metrics and business models and most important of all he knows how’s the life with a VC from the both sides of a table. He’s an eternal optimist and enthusiast. His entrepreneur minded thinking is greatly valued by his portfolio companies.


Surgify Medical Oy

Surgify Medical Oy is a surgical technology company headquartered in Helsinki, Finland, and was founded in 2017. The company is developing technology solutions to protect the soft tissues and prevent associated complications during bone surgeries.

Surgify’s cutting technology is developed in close collaboration with the Neurosurgical Department of Helsinki University Central Hospital in Finland, ensuring the fulfillment of clinicians’ needs.

“We see our solution as part of a bigger change that is happening in surgery, and that enables wider use of automation in many types of procedures. We envision enabling surgeons to utilize their surgical skills beyond the limitations of current surgical instrumentation, allowing best-in-class surgical procedures for every patient and cost-efficient innovation in healthcare” says Surgify’s CEO, Visa Sippola.

Surgify Medical Oy has received a governmental research grant from Business Finland and Aalto University, as well as funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 878204 for the development of Surgify Safety Burr™.